Skip to main content
Rise up! Award for Özgün Göcke

Honors & Funding

Özgün Göcke receivs Rise up! Award 2024

The Rise up! programme is aimed at outstanding and unusually creative basic researchers from the fields of biology, chemistry and medicine who have accepted a W2 professorship at a German university for the first time. The award is endowed with up to 600,000 euros each. 

The Boehringer Ingelheim Foundation recently awarded ImmunoSensation2 member Prof Özgün Gökce with the Rise up! award 2024. Göcke heads the ‘Systems Neuroscience - Cell Diversity’ working group at the Department of Neurodegenerative Diseases and Gerontopsychiatry at the UKB. The neurobiologist is looking for the key to the mechanisms of brain ageing. To this end, he plans to use new spatial transcriptomics technologies to investigate the basic principles of the nervous system in both healthy and diseased states. His project focuses on investigating how lipids alter and modulate adaptive and innate immune responses in the context of ageing and neurodegeneration.

 

Contact

Prof. Özgün Göcke

Medical Faculty, University of Bonn

& German Center for Neurodegenerative Diseases

mail: Ozgun.Goekce@ukbonn.de

 


 

 

Related news

Speakers of ImmunoSensation

Honors & Funding

ImmunoSensation goes into the next round

—The Bonn Cluster of Excellence ImmunoSensation will be funded for further seven years as part of the Excellence Strategy of the German federal and state governments. The aim of the new funding period, which begins on January 1, 2026, is to research immune diversity: the structural, functional and dynamic diversity of the immune system. Involved are the University of Bonn, the University Hospital Bonn (UKB) and the German Center for Neurodegenerative Diseases (DZNE). The funding amounts to around 50 million euros.
View entry
Kerstin Ludwig

Honors & Funding

Genome data to improve diagnosis and treatment of long Covid

—Despite the many advances, there are still major gaps in the care of patients with long-term and post-COVID. The Institute of Human Genetics at the UKB in Bonn now begins a genomLC study as part of a BMG funding priority. The researchers want to help speed up the diagnosis of long- and post-COVID and identify possible biomarkers that could possibly also differentiate between subgroups of the diseases. To this end, the genomic data of those affected is being analyzed as part of a study using blood samples. The project is funded by the Federal Ministry of Health (BMG) with 1.34 million euros.
View entry
Reckzeh News

Honors & Funding

Creating Personalized Cancer Treatments

—Bonn researchers aim to improve colon cancer treatment using 3D organoids and digital twins. Funded by the Federal Ministry of Education and Research (BMBF), a collaborative project involving the University of Bonn, the company ESQlabs and the University Hospital Bonn is seeking to refine the therapy recommendations given to colon cancer patients. To this end, “ISPOT-K” is merging organoids taken from patients with the power of digital twin technology.
View entry

Back to the news overview